about
Usefulness of reinforcing interventions on continuous positive airway pressure complianceExtreme REM Rebound during Continuous Positive Airway Pressure Titration for Obstructive Sleep Apnea in a Depressed Patient.Quality of life in patients at first time visit for sleep disorders of breathing at a sleep centre.Management of obstructive sleep apnea in Europe.The European Sleep Apnoea Database (ESADA): report from 22 European sleep laboratories.Public health and medicolegal implications of sleep apnoea.Pulmonary haemodynamics in obstructive sleep apnoea.A negative expiratory pressure test during wakefulness for evaluating the risk of obstructive sleep apnea in patients referred for sleep studies.Effect of obstructive sleep apnea diagnosis on health related quality of lifeObstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver DiseaseImmediate effect of CPAP titration on perceived health related quality of life: a prospective observational study.Respiratory disorders during sleep in chronic obstructive pulmonary disease.Hyperuricemia and non-dipping blood pressure.Gel pillow designed specifically for obstructive sleep apnea treatment with continuous positive airway pressure.Research update for articles published in EJCI in 2013.Successful treatment of atelectasis with Dornase alpha in a patient with congenital muscular dystrophy.Continuous positive airway pressure improves the quality of sleep and oxygenation in obstructive sleep apnea syndrome.Effects of positive end expiratory pressure administration during non-invasive ventilation in patients affected by amyotrophic lateral sclerosis: A randomized crossover study.Chronic kidney disease in European patients with obstructive sleep apnea: the ESADA cohort study.Comorbidities and survival in obstructive sleep apnoea beyond the age of 50.Sleep structure correlates of continuous positive airway pressure variations during application of an autotitrating continuous positive airway pressure machine in patients with obstructive sleep apnea syndrome.Personalised medicine in sleep respiratory disorders: focus on obstructive sleep apnoea diagnosis and treatment.A new method of negative expiratory pressure test analysis detecting upper airway flow limitation to reveal obstructive sleep apnea.Abnormal thyroid hormones and non-thyroidal illness syndrome in obstructive sleep apnea, and effects of CPAP treatment.Role of different nocturnal monitorings in the evaluation of CPAP titration by autoCPAP devices.Automatic titration and calculation by predictive equations for the determination of therapeutic continuous positive airway pressure for obstructive sleep apnea.The puzzle of metabolic effects of obstructive sleep apnoea in children.Relaxin in Obstructive Sleep Apnea: Relationship with Blood Pressure and Inflammatory Mediators.The microbiome and secondary lung disease in neuromuscular patients: Is it time to change our clinical practice?Liver Steatosis and Fibrosis in OSA patients After Long-term CPAP Treatment: A Preliminary Ultrasound Study.Adenotonsillectomy and sleep apnea in children.Subjective sleep quality in stable neuromuscular patients under non-invasive ventilation.Monitoring noninvasive ventilation in neuromuscular patients: feasibility of unattended home polysomnography and reliability of sleep diaries.Gender-specific anthropometric markers of adiposity, metabolic syndrome and visceral adiposity index (VAI) in patients with obstructive sleep apnea.Asynchronies and sleep disruption in neuromuscular patients under home noninvasive ventilation.Blood pressure changes after automatic and fixed CPAP in obstructive sleep apnea: relationship with nocturnal sympathetic activity.Obstructive sleep apnoea and metabolic syndrome in Mediterranean countries.Efficacy and comfort of volume-guaranteed pressure support in patients with chronic ventilatory failure of neuromuscular origin.Effects of continuous positive airway pressure therapy on hypertension control in patients with sleep-related breathing disorders: available evidence and unresolved issues.Complex sleep apnea and obesity hypoventilation syndrome. Opposite ends of the spectrum of obstructive sleep apnea?
P50
Q33593115-A23E25D9-8CE8-44E9-9226-10F28F565EB1Q33625351-0345C7A6-9134-487C-91C0-5A8F36170044Q33644277-056E2B8C-13DA-4695-8332-3CA94482AED6Q34155503-5B233C9D-017F-4BA2-BAEF-387D7D7CC286Q34188199-E41E3F36-C457-42DD-89B8-34011ABA2C8DQ35035029-987DA681-F9E1-463C-AADE-5954E6B5AC2CQ35046790-E85541E1-F9E3-4752-B99E-75A1804F83F9Q35473248-D6683ACE-D7E3-4D03-B4DF-9A065E67FEC5Q35658923-3A1DF230-030E-4A25-94E6-9B83562BF998Q35870004-C677B089-C691-40DE-9BB2-CC41BF3611E1Q36209080-89ADCF00-655E-46ED-862C-F33A1B044DD5Q37017327-B8ADF903-4AC8-412F-AFCC-823522E74E6DQ37378532-B16629D3-A0F9-44AC-B012-187FB7B38DD3Q37392352-DBA2807E-2C56-4042-8F53-3F39E3CA4C33Q38852737-2C92377D-B48D-4AA2-93FC-D22EFB530ED5Q39219599-28A2CFA8-A110-4CF2-B358-995DF371D693Q39538387-D8B246F2-653F-42B7-AB3A-F9F6C4E58C2AQ39669650-F17D9AA1-66CA-47FE-98B3-7B8FFDC8C5B8Q39757312-9A8AB5C4-E034-42FE-9770-37045B5352ADQ46858192-7949940F-3DFA-4C52-BB58-7EB1CCE07CC3Q47191053-10A1A2BD-F86F-468C-9CB1-B2BE306B0761Q47668960-46E8B8B5-3A05-4006-8F51-920C2A0DD119Q47706832-9C3BC925-A281-4298-8F03-06F9974837E4Q47810935-AD97928E-6EA6-4F3A-A931-A8245C93705FQ47843177-525D14FA-0A6C-42FE-A959-AC829DCD6275Q47865855-3AAFCE7C-284C-4B06-8219-11429E01283AQ47871962-C4EB255C-BE7C-46DA-B321-14E1C35DB4F3Q47903254-2F712C3C-74FD-4D6C-9B8A-F09CB79B327AQ47930034-C7EE937F-979C-4A42-BA9D-85F56CACEE89Q47935849-D57B6FDB-5FD8-4BB2-BBE9-72E41869DDDCQ47970504-3860D0D3-F16B-4009-A459-F9890BFE7460Q48033776-4EF65346-FDE8-4B97-9169-53EB46FE2E10Q48126452-8582EE5A-84A2-4D83-AC9E-1C3D82C59948Q48150025-255FD313-210E-4B8F-990C-2E25862CAF13Q48235765-30FE7905-45A7-4B65-A6DC-DA3B83CF611DQ48305422-84E364DE-68B4-4181-953D-357AF36E7C38Q48314712-9BD6DC4D-024A-4922-B63F-7AE2ED0B3208Q48314841-24888E8A-680C-4796-B43B-24C05D854486Q48340638-DF14ED31-88D5-42C4-87B4-297FC7F67775Q48394750-EAE2D0FB-CE3B-4A1A-8832-22DDC82FC1B4
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Oreste Marrone
@ast
Oreste Marrone
@en
Oreste Marrone
@es
Oreste Marrone
@nl
Oreste Marrone
@sl
Орест Марроне
@ru
type
label
Oreste Marrone
@ast
Oreste Marrone
@en
Oreste Marrone
@es
Oreste Marrone
@nl
Oreste Marrone
@sl
Орест Марроне
@ru
prefLabel
Oreste Marrone
@ast
Oreste Marrone
@en
Oreste Marrone
@es
Oreste Marrone
@nl
Oreste Marrone
@sl
Орест Марроне
@ru
P106
P1153
7004223392
P21
P31
P496
0000-0001-6819-7928